Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers and localized infectious diseases. We are dedicated to fostering the development of chemotherapeutics based on the technology platform, utilizing molecular photoswitches.
Our drug candidates are peptidic therapeutics, modified by photoisomerizable building blocks. They can toggle between two forms, inactive and active, upon irradiation with light of different wavelength. The inactive (and non-toxic) photoswitchable peptidic drugs are administered to the patients. Switching the biological activity “on” with non-thermal red light irradiation in the sites of lesions (tumors, wounds) allows avoiding side-effects in the healthy tissues.
Current target indications: bladder cancers, hepatocellular carcinoma, implant infections.
Company Details
- Founded
- -
- Address
- Karlsruhe, Baden-Württemberg
- co****@****ics.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- lumobiotics.com
- Keywords
- Biotechnology, Pharmaceuticals, Oncology, Infectious diseases, Peptides, Drug development, Peptidomimetics, Therapeutics, Startup, Photoswitchable drugs.
- HQ
- Karlsruhe, Baden-Württemberg
Lumobiotics Gmbh Questions
Lumobiotics Gmbh's website is lumobiotics.com
Lumobiotics Gmbh's LinkedIn profile is https://de.linkedin.com/company/lumobiotics
Lumobiotics Gmbh's industry is
Pharmaceutical Manufacturing
Lumobiotics Gmbh's top competitors are
Biochem Labor Für Biologische Und Chemische Analytik Gmbh,
Xrf Expertise,
Incephalo,
Drug Discovery World,
Instraction,
Antea Medizintechnik Und Informationstechnik,
Fast Forward Discoveries Gmbh,
Hummingbird Diagnostics Gmbh,
Allied Biotech Corporation,
Hs Analysis Gmbh.
Lumobiotics Gmbh's support email address is contact@lumobiotics.com
Lumobiotics Gmbh's categories are Pharmaceutical Manufacturing
Lumobiotics Gmbh's founding year is 2017
